Abstract:Problems, such as toxic side effects and drug resistance of chemoradiotherapy, target therapy and immunotherapy accompanying the current anti-cancer treatments, have become bottlenecks limiting the clinical benefit for patients. Therefore, it is urgent to find promising anti-cancer strategies with higher efficacy and lesser side effects. Baicalein, a flavonoid component derived from the Chinese medicine scutellaria baicalensis, has been widely studied for its remarkable anti-cancer activity in multiple types of malignancies both at the molecular and cellular levels. Baicalein exerts its anti-tumor effects by inhibiting angiogenesis, invasion and migration, inducing cell apoptosis and cell cycle arrest, as well as regulating cell autophagy, metabolism, the tumor microenvironment and cancer stem cells with no obvious toxic side effects. The role of classic signaling pathways, such as PI3K/AKT/mTOR, MAPK, AMPK, Wnt/β-catenin, JAK/STAT3, MMP-2/-9, have been highlighted as the major targets for baicalein exerting its anti-malignant potential. Besides, baicalein can regulate the relevant non-coding RNAs, such as lncRNAs, miRNAs and circ-RNAs, to inhibit tumorigenesis and progression. In addition to the mentioned commonalities, baicalein shows some specific anti-tumor characteristics in some specific cancer types. Moreover, the preclinical studies of the combination of baicalein and chemoradiotherapy pave the way ahead for developing baicalein as an adjunct treatment with chemoradiotherapy. Our aim is to summary the role of baicalein in different types of cancer with its mechanisms based on in vitro and in vivo experiments, hoping providing proof for baicalein serving as an effective and safe compound for cancer treatment in clinic in the future.

Latest research progress on anticancer effect of baicalin and its aglycone baicalein

Exploring the Chemopreventive Properties and Perspectives of Baicalin and Its Aglycone Baicalein in Solid Tumors

The most recent progress of baicalein in its anti-neoplastic effects and mechanisms

Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives

Baicalin mediated regulation of key signaling pathways in cancer

Exploring Therapeutic Potentials of Baicalin and Its Aglycone Baicalein for Hematological Malignancies.

Baicalein and Baicalin Inhibit Colon Cancer Using Two Distinct Fashions of Apoptosis and Senescence

Multiple roles of baicalin and baicalein in the regulation of colorectal cancer

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

The Extraction, Anticancer Effect, Bioavailability, and Nanotechnology of Baicalin

Pretreatment of baicalin and wogonoside with glycoside hydrolase: a promising approach to enhance anticancer potential.

Scutellaria baicalensis and Cancer Treatment: Recent Progress and Perspectives in Biomedical and Clinical Studies.

The therapeutic effect of baicalin in the treatment of bladder cancer: a mini-review

Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs

Baicalein: A Review of Its Anti-Cancer Effects and Mechanisms in Hepatocellular Carcinoma.

In Vitro Studies Of Baicalin Alone Or In Combination With Salvia Miltiorrhiza Extract As A Potential Anti-Cancer Agent

Potential therapeutic effects of baicalin and baicalein

Baicalein: A review on its anti-cancer effects and mechanisms in lung carcinoma

Baicalin and its aglycone: a novel approach for treatment of metabolic disorders

Baicalin and Baicalein Enhance Cytotoxicity, Proapoptotic Activity, and Genotoxicity of Doxorubicin and Docetaxel in MCF-7 Breast Cancer Cells

Research progress on pharmacological effects and new dosage forms of baicalin